US Patent Issued to Covis Pharma on July 29 for "Pharmaceutical aerosol product for administration by oral or nasal inhalation" (German, American Inventors)

ALEXANDRIA, Va., July 30 -- United States Patent no. 12,370,141, issued on July 29, was assigned to Covis Pharma GmbH (Zug, Switzerland).

"Pharmaceutical aerosol product for administration by oral or nasal inhalation" was invented by Helgert Muller (Radolfzell, Germany), Renate Engelstatter (Allensbach, Germany), Ulrich Bildmann (Hilzingen, Germany), Andrea Bauer (North Reading, Mass.) and Paul McGlynn (Northborough, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "This invention relates to a pharmaceutical aerosol product suitable for administration by oral or nasal inhalation and its use in the treatment of respiratory diseases, in particular in the treatment of children. The aerosol composition compri...